Dose: 3 to 12 mg
Single Dose: 7.5 (7.5)
Frequency: As recommended.
Route: PO
Instructions: 3-4 times daily.

. The Molecular Weight of Nylidrin is 335.87.

Nylidrin is contraindicated in conditions like Myocardial infarction,Thyrotoxicosis,Angina pectoris,Tachycardia,Hypersensitivity to the drug.

The signs and symptoms that are produced after the acute overdosage of Nylidrin include Blurred vision, Fever, Metallic taste, Chest pain.The symptomatic adverse reactions produced by Nylidrin are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Nervousness, Chills, Flushing, Nausea and vomiting, Trembling, nervousness, Nervousness.

'Nylidrin is primarily indicated in conditions like Arteriosclerosis, Cerebrovascular disease, Peripheral vascular disease, Raynaud''s disease, Thromboangiitis obliterans, Thrombophlebitis.'

No data regarding the interactions of Nylidrin was found.

Drug should not be given to Pregnant Mothers, Geriatrics, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Tablets Protect from Sunlight and Heat.

'Warnings and precautions should be considered if the patient have any pre-existing conditions, such as: chest pain, heart disease, thyroid disease, ulcers, any allergies. This medication should be used only if clearly needed during pregnancy. Discuss the risks and benefits with your doctor. It is not known if this medication is found in breast milk. Consult your doctor before breast-feeding. Nylidrin is not indicated in the management of normal aging or of patients with presenile dementia (Alzheimer''s Disease).'